Nad's For Men Down Under Hair Removal Cream, Hair Removal Cream for Male Intimate Areas and Genitals, ‎All Skin Types 150 ml

Product Information

Haffner, C. D. et al. Discovery, synthesis, and biological evaluation of thiazoloquin(az)olin(on)es as potent CD38 inhibitors. J. Med. Chem. 58, 3548–3571 (2015). Pirinen, E. et al. Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 19, 1034–1041 (2014). Boslett, J., Hemann, C., Zhao, Y. J., Lee, H.-C. & Zweier, J. L. Luteolinidin protects the postischemic heart through CD38 inhibition with preservation of NAD(P)(H). J. Pharmacol. Exp. Ther. 361, 99–108 (2017). Chiarugi, A.; Dölle, C.; Felici, R.; Ziegler, M. The NAD metabolome-a key determinant of cancer cell biology. Nat. Rev. Cancer 2012, 12, 741–752. [ Google Scholar] [ CrossRef]

Fagnoni, F. F. et al. Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians. Immunology 88, 501–507 (1996). Das, A. et al. Impairment of an endothelial NAD +-H 2S signaling network is a reversible cause of vascular aging. Cell 173, 74–89.e20 (2018). Yang, H. et al. Nutrient-sensitive mitochondrial NAD + levels dictate cell survival. Cell 130, 1095–1107 (2007). Dollerup, O. L. et al. Effects of nicotinamide riboside on endocrine pancreatic function and incretin hormones in nondiabetic men with obesity. J. Clin. Endocrinol. Metab. 104, 5703–5714 (2019).Banerjee, S. et al. CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia. J. Neuroimmune Pharmacol. 3, 154–164 (2008).

Rudolphi, B. et al. Body weight predicts nicotinamide N-methyltransferase activity in mouse fat. Endocr. Res. 43, 55–63 (2018). Saleh, T.; Bloukh, S.; Carpenter, V.J.; Alwohoush, E.; Bakeer, J.; Darwish, S.; Azab, B.; Gewirtz, D.A. Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy. Cancers 2020, 12, 822. [ Google Scholar] [ CrossRef] [ PubMed][ Green Version] Youm, Y.-H. et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 18, 519–532 (2013). Varga, J.; De Oliveira, T.; Greten, F.R. The architect who never sleeps: Tumor-induced plasticity. FEBS Lett. 2014, 588, 2422–2427. [ Google Scholar] [ CrossRef] [ PubMed][ Green Version]

SHOP ONLINE

Komatsu, M. et al. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD metabolism. Sci. Rep. 8, 8637 (2018). Milanovic, M.; Fan, D.N.Y.; Belenki, D.; Däbritz, J.H.M.; Zhao, Z.; Yu, Y.; Dörr, J.R.; Dimitrova, L.; Lenze, D.; Monteiro Barbosa, I.A.; et al. Senescence-associated reprogramming promotes cancer stemness. Nature 2018, 553, 96–100. [ Google Scholar] [ CrossRef][ Green Version] Trammell, S.A.; Brenner, C. NNMT: A Bad Actor in Fat Makes Good in Liver. Cell Metab. 2015, 22, 200–201. [ Google Scholar] [ CrossRef] [ PubMed][ Green Version]

Lee, K.-A. et al. Characterization of age-associated exhausted CD8 + T cells defined by increased expression of Tim-3 and PD-1. Aging Cell 15, 291–300 (2016). Mikuła-Pietrasik, J.; Niklas, A.; Uruski, P.; Tykarski, A.; Książek, K. Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells. Cell. Mol. Life Sci. 2020, 77, 213–229. [ Google Scholar] [ CrossRef][ Green Version] Hogan, K. A., Chini, C. C. S. & Chini, E. N. The multi-faceted ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases. Front. Immunol. 10, 1187 (2019).Hao, C.; Zhu, P.X.; Yang, X.; Han, Z.P.; Jiang, J.H.; Zong, C.; Zhang, X.G.; Liu, W.T.; Zhao, Q.D.; Fan, T.T.; et al. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma. BMC Cancer 2014, 14, 978. [ Google Scholar] [ CrossRef][ Green Version] Martin, A. S. et al. Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich’s ataxia cardiomyopathy model. JCI Insight 2, e93885 (2017).